Two separate questions get collapsed into one here, and they have opposite answers. Does a routine workplace drug panel look for anything in a mushroom supplement? No — not a single target analyte on a standard five- or ten-panel screen corresponds to any mushroom compound. Can Amanita muscaria's active compounds be detected in urine at all? Yes, by a published liquid chromatography-mass spectrometry method with a limit of detection of 40 ng/ml for muscimol. Whether anyone runs that method is a completely different matter from whether it exists.
Standard urine drug screens are immunoassays targeting a fixed list — amphetamines, cannabinoids, cocaine metabolite, opiates, phencyclidine, and on extended panels benzodiazepines, barbiturates, methadone and others. No mushroom compound is on that list, and none is structurally similar enough to the targets to be a plausible cross-reactant. A dedicated LC-MS method for ibotenic acid, muscimol and muscarine in human urine has existed since 2008 with detection limits of 50, 40 and 3 ng/ml, so detection is a matter of choosing to look. Amanita muscaria contains no psilocybin, so psilocybin-specific testing does not apply to it. For athletes the documented risk is not the mushroom at all: reviews of dietary supplements report WADA-prohibited substances present in 12–58% of products analysed, none of them declared on the label.
The honest framing throughout is disclosure rather than concealment. Nothing below is a method for passing a test you should not pass; it is what the tests do and do not measure.
What a Standard Panel Actually Tests For
A fixed and short list. Workplace and clinical urine screens are immunoassays: antibodies raised against a specific drug class, producing a colour or fluorescence change when the target is present above a cut-off concentration.
The classic five-panel covers amphetamines, cannabinoids, cocaine metabolite, opiates and phencyclidine. Ten- and twelve-panel versions add benzodiazepines, barbiturates, methadone, propoxyphene, methaqualone and oxycodone. Every one of those is a defined chemical target with a defined antibody.
Nothing in that architecture searches for unknown compounds. An immunoassay cannot report "something unusual is present"; it can only report whether its own target appears to be there.
Can a Mushroom Cause a False Positive?
There is no documented case, and the chemistry does not suggest one. False positives are a genuine and well-catalogued phenomenon — Saitman's review of false-positive urine drug screens covers the culprits, which are typically medications and foods structurally similar to the target analyte. Ranitidine interfering with amphetamine immunoassays is a documented example.
Muscimol is a small isoxazole. Beta-glucans are polysaccharides. Ganoderic acids are triterpenes. None of them resembles an amphetamine, an opiate, a cannabinoid or a benzodiazepine closely enough to bind an antibody raised against those molecules.
Absence of reported cases is not proof of impossibility, and it is worth saying so. But there is no mechanism here and no case series, which is about as reassuring as this kind of question gets.
The Amanita Muscaria Question
This is where the honest answer has two parts.
Part one: Amanita muscaria is not a psilocybin mushroom. Its active compounds are ibotenic acid and muscimol, acting on GABA-A receptors, and it contains no psilocybin or psilocin. Testing designed to detect psilocybin metabolites — which is itself uncommon and not part of routine panels — does not detect Amanita compounds. Our comparison of the two sets out why they are pharmacologically unrelated.
Part two: muscimol is detectable when someone decides to look for it. Merova's 2008 method isolates and identifies ibotenic acid, muscimol and muscarine in human urine by liquid chromatography-mass spectrometry, with limits of detection of 50 ng/ml, 40 ng/ml and 3 ng/ml respectively.
That method exists for clinical toxicology — identifying what somebody was poisoned by — not for employment screening. But a laboratory asked a specific question can answer it, which means the practical protection is legality and disclosure, not undetectability. Legal status varies widely by jurisdiction, as our legal status guide explains.
For Athletes: The Risk Is the Supply Chain
No mushroom species appears on the WADA Prohibited List. Cordyceps is not banned, reishi is not banned, lion's mane is not banned. Taken as clean single-species products they are not a doping question.
The documented risk sits elsewhere. Martínez-Sanz's 2017 review examined 23 studies analysing dietary supplements for substances banned by WADA and found prohibited compounds — mostly prohormones and stimulants — in most of the products tested, with contamination rates between 12% and 58%.
None of it was declared on the label, which is the whole point. An athlete who tests positive after taking a supplement is almost never testing positive for the ingredient on the front of the pack.
The exposure concentrates in multi-ingredient "performance" blends rather than single-species mushroom powders, because those are the products where an adulterant would actually do something a buyer would notice. Under strict liability rules, the athlete carries the consequence regardless.
What Each Test Actually Covers
| Test type | What it looks for | Mushroom compounds detected? |
|---|---|---|
| 5-panel workplace urine screen | Amphetamines, cannabinoids, cocaine, opiates, PCP | None |
| 10/12-panel urine screen | The above plus benzodiazepines, barbiturates, methadone and others | None |
| Hair testing | Same drug classes, longer window | None |
| Psilocybin-specific assay | Psilocin metabolites | Not applicable — Amanita contains no psilocybin |
| Clinical toxicology LC-MS | Whatever it is configured to find | Yes, if configured for muscimol (LOD 40 ng/ml) |
| WADA anti-doping testing | The Prohibited List | No mushroom is listed; adulterants are the risk |
Roadside and Impairment Testing
A different category again, and worth separating. Roadside drug testing devices screen for the same standard drug classes and will not detect mushroom compounds.
Impairment is not the same as detection, though. Amanita muscaria acts on GABA-A receptors, the same family targeted by alcohol and sedatives, and an impairment assessment by a trained officer does not depend on a chemical test at all. Nothing about a negative panel makes it acceptable to drive after taking a sedating substance.
What to Do
- Declare supplements when asked. Medical review officers and pre-employment forms ask for a reason; an accurate list protects you if anything anomalous appears.
- If you compete, buy batch-certified products. Third-party batch testing against the Prohibited List is the only thing that addresses a 12–58% contamination rate.
- Prefer single-species products. A one-ingredient mushroom powder has far less scope for an undeclared additive than a multi-ingredient performance blend — see blends versus single species.
- Do not treat Amanita muscaria as undetectable. A validated urine method exists; legality in your jurisdiction is the thing that matters, not what a panel happens to screen for.
- Do not conflate Amanita with psilocybin mushrooms. Different compounds, different receptors, different legal status in most countries.
- Never drive on anything sedating. Impairment assessment does not require a positive chemical test.
The Honest Summary
Routine drug testing does not look for mushroom compounds, no mushroom is a plausible immunoassay cross-reactant, and no false-positive case has been reported. That answers the question most people are actually asking.
Two caveats keep it honest. Detection of Amanita muscaria compounds is technically straightforward for a laboratory that decides to look, so undetectability is not a legal strategy. And for competing athletes the mushroom was never the risk — the risk is that somewhere between one in eight and one in two supplements analysed in the published literature contained a prohibited substance nobody put on the label.
Frequently Asked Questions
Will lion's mane or reishi show up on a drug test?
No. Standard panels are immunoassays targeting a fixed list of drug classes, and no mushroom compound is on that list or structurally close enough to any target to cross-react. No false-positive case involving a mushroom supplement has been published.
Does Amanita muscaria show up on a drug test?
Not on a routine panel, which does not test for it. A published liquid chromatography-mass spectrometry method detects muscimol in urine down to 40 ng/ml, so a laboratory that specifically looks can find it — detectability depends on what is being tested for, not on the compound being invisible.
Is Amanita muscaria the same as a psilocybin mushroom?
No. It contains ibotenic acid and muscimol, which act on GABA-A receptors, and no psilocybin or psilocin at all. Testing aimed at psilocybin metabolites does not apply to it.
Are mushroom supplements banned in sport?
No mushroom species appears on the WADA Prohibited List. The documented risk for athletes is undeclared contamination of supplements generally — prohibited substances were found in 12% to 58% of products across the studies in one review.
How can an athlete reduce the risk?
Choose single-ingredient products and insist on batch-level third-party certification against the Prohibited List. Species choice does nothing about contamination; batch testing is the only control that addresses it.
Shop Single-Ingredient Products
Fewer ingredients means fewer places for something undeclared to hide. Cordyceps capsules (120 caps €49) and Lion's mane capsules (120 caps €49) are each a single species with nothing added, and Chaga chunks (100 g €25, 300 g €39) are whole unprocessed material. Free shipping on orders over €50.
Related Articles
- Amanita Muscaria Legal Status by Country
- How Amanita Muscaria Differs From Psilocybin Mushrooms
- Best Mushrooms for Athletes
- Mushroom Blend vs Single Species
- Heavy Metals in Mushroom Supplements
- How to Read a Certificate of Analysis
- Amanita muscaria Side Effects and Interactions
Sources
- Merova B, Ondra P, Stankova M, Valka I. Isolation and identification of the Amanita muscaria and Amanita pantherina toxins in human urine. Neuro Endocrinol Lett. 2008;29(5):744-748. PubMed 18987593
- Martínez-Sanz JM, Sospedra I, Ortiz CM, Baladia E, Gil-Izquierdo A, Ortiz-Moncada R. Intended or unintended doping? A review of the presence of doping substances in dietary supplements used in sports. Nutrients. 2017;9(10):1093. PubMed 28976928
- Saitman A. False positive urine drug screens. J Anal Toxicol. 2026;50(4). PubMed 41639014
- Ginterová P, Marcák M, Zavadská M, et al. Determination of mushroom toxins ibotenic acid, muscimol and muscarine by capillary electrophoresis coupled to electrospray tandem mass spectrometry. Talanta. 2014;125:242-247. PubMed 24840440
- Kozhuharov VR, Ivanov K, Ivanova S. Dietary supplements as source of unintentional doping. Biomed Res Int. 2022;2022:8387271. PubMed 35496041